S
Singular Genomics Systems Inc
NASDAQ:OMIC
Singular Genomics Systems Inc
NASDAQ:OMIC
Price:
0.4 USD
-1.74%
Market Closed
Updated:
May 3, 2024
Singular Genomics Systems Inc
Net Income (Common)
|
Singular Genomics Systems Inc
Net Income (Common) Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Net Income (Common)
-$94.8m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$788.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Singular Genomics Systems Inc's Net Income (Common)?
Net Income (Common)
-94.8m
USD
-94.8m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Net Income (Common) amounts to -94.8m USD.
What is Singular Genomics Systems Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-50%
-50%
Over the last year, the Net Income (Common) growth was -4%. The average annual Net Income (Common) growth rates for Singular Genomics Systems Inc have been -50% over the past three years .
You don't have any saved screeners yet
